
Overview
Ronald L. Hrebinko, MD, is a professor of urology at the University of Pittsburgh School of Medicine. He specializes in all genitourinary cancers with special expertise in continent urinary diversion, nephron-sparing surgery for renal cancer, laparoscopic kidney surgery, nerve-sparing surgery for the prostate, and testis cancer. Dr. Hrebinko is board-certified in urology. He received an undergraduate degree with honors from Dartmouth College in N.H., and a medical degree at the University of Pittsburgh School of Medicine. Dr. Hrebinko completed a residency at UPMC in the Department of Surgery, and a fellowship at Roswell Park Cancer Institute, in Buffalo, N.Y. Dr. Hrebinko is a member of professional organizations, such as the American Urologic Association, Society of Urologic Oncology, and the American Society of Clinical Oncology. Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule.
Dr. Hrebinko is rated as an Advanced provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, Nephrectomy, and Reconstructive Urology Surgery.
His clinical research consists of co-authoring 16 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5200 Centre Avenue, Suite 209, Pittsburgh, PA 15232
1300 Oxford Drive, Suite 1200, Bethel Park, PA 15102
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
University Of Pittsburgh Physicians
Leonard Appleman is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Appleman is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, and Chromophobe Renal Cell Carcinoma.
West Virginia University Medical Corporation
Thomas Hogan is a Hematologist Oncology specialist and an Oncologist in Morgantown, West Virginia. Dr. Hogan is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Renal Cell Carcinoma (RCC).
David Friedland is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Friedland is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Renal Cell Carcinoma (RCC)Dr. Hrebinko isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Advanced
- Bladder CancerDr. Hrebinko isAdvanced. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Hrebinko isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Hrebinko isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Hrebinko isAdvanced. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Hrebinko isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- NephrectomyDr. Hrebinko isAdvanced. Learn about Nephrectomy.
- Experienced
- Bilateral HydronephrosisDr. Hrebinko isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder ReconstructionDr. Hrebinko isExperienced. Learn about Bladder Reconstruction.
- BoilsDr. Hrebinko isExperienced. Learn about Boils.
- CarbuncleDr. Hrebinko isExperienced. Learn about Carbuncle.
- CystectomyDr. Hrebinko isExperienced. Learn about Cystectomy.
- EmpyemaDr. Hrebinko isExperienced. Learn about Empyema.
